Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study
Junxi Pan, Jinjun Xia, Feng-Li Deng, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders
Jian Yang, Peng Zheng, Yifan Li, et al.
Science Advances (2020) Vol. 6, Iss. 49
Open Access | Times Cited: 278
Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System
Raluca Ioana Teleanu, Adelina-Gabriela Niculescu, Eugenia Roza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5954-5954
Open Access | Times Cited: 275
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies
Wolfgang Marx, Amelia J. McGuinness, Tetyana Rocks, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 4158-4178
Closed Access | Times Cited: 231
An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder
Juncai Pu, Yiyun Liu, Hanping Zhang, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 4265-4276
Open Access | Times Cited: 182
Microbiota alterations in proline metabolism impact depression
Jordi Mayneris‐Perxachs, Anna Castells‐Nobau, Maria Arnoriaga‐Rodríguez, et al.
Cell Metabolism (2022) Vol. 34, Iss. 5, pp. 681-701.e10
Open Access | Times Cited: 154
Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis
Hui-Ling Wei, Chunyang Yu, Chun Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114308-114308
Open Access | Times Cited: 95
Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome
Zahra Amirkhanzadeh Barandouzi, Joochul Lee, Maria del Carmen Rosas, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 76
Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023)
Magdalena Zielińska, Edyta Łuszczki, Katarzyna Dereń
Nutrients (2023) Vol. 15, Iss. 11, pp. 2433-2433
Open Access | Times Cited: 46
Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder
Zuoquan Xie, Jingjing Huang, Guangqiang Sun, et al.
Psychiatry Research (2024) Vol. 334, pp. 115804-115804
Open Access | Times Cited: 24
Molecular basis underlying changes of brain entropy and functional connectivity in major depressive disorders after electroconvulsive therapy
Xiaohui Yu, Kexuan Chen, Yingzi Ma, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 19
Bacterial Metabolites of Human Gut Microbiota Correlating with Depression
Olga V. Averina, Yana Zorkina, Roman А. Yunes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9234-9234
Open Access | Times Cited: 131
Recent advancement in nanosensors for neurotransmitters detection: Present and future perspective
Nidhi Chauhan, Shringika Soni, Prabhudatt Agrawal, et al.
Process Biochemistry (2019) Vol. 91, pp. 241-259
Closed Access | Times Cited: 81
Walnut‐Derived Peptide PW5 Ameliorates Cognitive Impairments and Alters Gut Microbiota in APP/PS1 Transgenic Mice
Min Wang, William Kwame Amakye, Lu Guo, et al.
Molecular Nutrition & Food Research (2019) Vol. 63, Iss. 18
Closed Access | Times Cited: 77
The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites
Francesco Bartoli, Błażej Misiak, Tommaso Callovini, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3419-3429
Closed Access | Times Cited: 75
Challenges for Artificial Intelligence in Recognizing Mental Disorders
Wen‐Jing Yan, Qian-Nan Ruan, Ke Jiang
Diagnostics (2022) Vol. 13, Iss. 1, pp. 2-2
Open Access | Times Cited: 41
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation
Flora Tassone, Dragana Protić, Emily G. Allen, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2330-2330
Open Access | Times Cited: 34
Major depressive disorder: Biomarkers and biosensors
Masoomeh Dadkhah, Mohsen Jafarzadehgharehziaaddin, Soheila Molaei, et al.
Clinica Chimica Acta (2023) Vol. 547, pp. 117437-117437
Closed Access | Times Cited: 24
Accelerometer-based physical activity is associated with the gut microbiota in 8416 individuals in SCAPIS
Gabriel Baldanzi, Sergi Sayols-Baixeras, Elin Ekblom‐Bak, et al.
EBioMedicine (2024) Vol. 100, pp. 104989-104989
Open Access | Times Cited: 13
Human microbiota from drug-naive patients with obsessive-compulsive disorder drives behavioral symptoms and neuroinflammation via succinic acid in mice
Ying-Dan Zhang, Dongdong Shi, Bing-Bing Liao, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1782-1797
Closed Access | Times Cited: 10
An integrated machine learning framework for developing and validating a diagnostic model of major depressive disorder based on interstitial cystitis-related genes
Bohong Chen, Xinyue Sun, Haoxiang Huang, et al.
Journal of Affective Disorders (2024) Vol. 359, pp. 22-32
Open Access | Times Cited: 10
Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients
Tingyu Zhao, Ting Liu, Lu Wang, et al.
Journal of Affective Disorders (2024) Vol. 349, pp. 332-341
Closed Access | Times Cited: 9
Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine
Fabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 9
Neurotransmitter-mediated artificial synapses based on organic electrochemical transistors for future biomimic and bioinspired neuromorphic systems
Miao Cheng, Yifan Xie, Jinyao Wang, et al.
Journal of Semiconductors (2025) Vol. 46, Iss. 1, pp. 011604-011604
Closed Access | Times Cited: 1
Urine Metabolomic Patterns to Discriminate the Burnout Levels and Night-Shift-Related Stress in Healthcare Professionals
Andreea Petra Ungur, Andreea Iulia Socaciu, Maria Bârsan, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 273-273
Open Access | Times Cited: 1
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
Hisayuki Erabi, Go Okada, Chiyo Shibasaki, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top